Hikma Pharmaceuticals PLC

LON-HIK
London Stock Exchange
Healthcare Drug Manufacturers - Specialty & Generic
Global Rank
#3021
Country Rank
#100
Market Cap
$5.68 B
Price
$2,574.6
Change (%)
1.27%
Volume
1.09 M

LON-HIK's Next Dividend

Next Estimated Amount
£0.24
Next Estimated Pay Date
12/10/2025
Last Amount
£0.37
Last Pay Date
05/01/2025
Dividend Shot Clock Ex-Date: 03/20/2025
0
Days
0
Hours
0
Minutes
0
Seconds
Ex-dividend date passed

Hikma Pharmaceuticals PLC Dividend Chart

*Amounts are shown in the stock exchange currency (GBP) for convenience

Hikma Pharmaceuticals PLC(LON-HIK) Dividend History

Hikma Pharmaceuticals PLC (LON-HIK) currently pays an annual dividend of $0.62 per share, offering a dividend yield of 3.11%. The next dividend payout date has not been announced. With 3 consecutive years of dividend growth, Hikma Pharmaceuticals PLC has steadily increased its payout at an average annual rate of 9.34%, demonstrating a consistent commitment to rewarding investors.
Ex-Dividend Date Amount Adj. Amount Dividend Yield Pay Date Change (%)
2025 £0.48 £0.37 -40%
03/20/2025 £0.48 £0.37 2.96% 05/01/2025 48%
2024 £0.79 £0.619 24%
08/15/2024 £0.32 £0.249 2.95% 09/20/2024 -33%
03/21/2024 £0.47 £0.37 2.89% 05/03/2024 88%
2023 £0.62 £0.499 15%
08/10/2023 £0.25 £0.197 2.21% 09/15/2023 -35%
03/23/2023 £0.37 £0.302 2.68% 05/05/2023 92%
2022 £0.55 £0.432 15%
08/18/2022 £0.19 £0.158 3.06% 09/20/2022 -43%
03/17/2022 £0.36 £0.275 1.99% 04/28/2022 110%
2021 £0.52 £0.376 -11%
08/19/2021 £0.18 £0.131 1.46% 09/20/2021 -47%
03/18/2021 £0.34 £0.245 1.62% 04/26/2021 102%
2020 £0.46 £0.421 5%
08/20/2020 £0.16 £0.121 1.47% 09/21/2020 -60%
03/19/2020 £0.3 £0.3 3.40% 05/07/2020 114%
2019 £0.4 £0.4 14%
08/22/2019 £0.14 £0.14 1.60% 09/23/2019 -46%
04/04/2019 £0.26 £0.26 1.59% 05/22/2019 117%
2018 £0.35 £0.35 6%
08/23/2018 £0.12 £0.12 1.42% 09/21/2018 -48%
04/05/2018 £0.23 £0.23 1.98% 05/24/2018 109%
2017 £0.33 £0.33 3%
08/24/2017 £0.11 £0.11 2.08% 09/22/2017 -50%
04/06/2017 £0.22 £0.22 1.37% 05/25/2017 100%
2016 £0.32 £0.32 0%
09/01/2016 £0.11 £0.11 1.14% 09/30/2016 -48%
04/07/2016 £0.21 £0.21 1.08% 05/19/2016 91%
2015 £0.32 £0.32 14%
08/27/2015 £0.11 £0.11 0.92% 09/25/2015 -48%
04/16/2015 £0.21 £0.21 0.99% 05/21/2015 91%
2014 £0.28 £0.28 40%
08/27/2014 £0.11 £0.11 0.96% 09/26/2014 -35%
04/23/2014 £0.17 £0.17 1.02% 05/22/2014 70%
2013 £0.2 £0.2 48%
09/04/2013 £0.1 £0.1 1.23% 10/07/2013 0%
04/17/2013 £0.1 £0.1 1.06% 05/23/2013 67%
2012 £0.135 £0.135 4%
08/29/2012 £0.06 £0.06 1.16% 10/08/2012 -20%
04/18/2012 £0.075 £0.075 1.24% 05/24/2012 36%
2011 £0.13 £0.13 8%
09/07/2011 £0.055 £0.055 1.41% 10/13/2011 -27%
04/13/2011 £0.075 £0.075 1.11% 05/26/2011 36%
2010 £0.12 £0.12 41%
09/08/2010 £0.055 £0.055 0.98% 10/14/2010 -15%
04/14/2010 £0.065 £0.065 1.52% 05/27/2010 44%
2009 £0.085 £0.085 13%
09/16/2009 £0.045 £0.045 1.09% 10/16/2009 12%
04/29/2009 £0.04 £0.04 1.33% 06/02/2009 14%
2008 £0.075 £0.075 0%
09/17/2008 £0.035 £0.035 0.95% 10/17/2008 -12%
04/30/2008 £0.04 £0.04 1.26% 06/02/2008 14%
2007 £0.075 £0.075 93%
09/26/2007 £0.035 £0.035 0.88% 10/26/2007 -12%
05/16/2007 £0.04 £0.04 0.96% 06/18/2007 33%
2006 £0.0389 £0.0389
09/27/2006 £0.03 £0.03 0.51% 10/27/2006 237%
04/26/2006 £0.0089 £0.0089 0.11% 05/30/2006
*Amounts are shown in the stock exchange currency (GBP) for convenience
*Historical information is adjusted for stock splits

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.